Month: August 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

by

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

by

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon, marking a new era of […]

KWS Prioritises Rangers’ Welfare

by

Kenya Wildlife Service (KWS) Acting Director General Dr. Erastus Kanga has assured Game Rangers of their welfare and that of their families as they carry out their duties. Kanga said that the government will continue improving the health insurance cov…

Turkana Develops Blueprint To Combat Prosopis Threat

by

Turkana County has taken steps to combat the destructive and invasive plant species Prosopis Juliflora, locally known as ‘Etirae’ by unveiling an ambitious ten-year plan. Chief Officer for Environment, Climate Change, and Natural Resources Joseph Ekal…